Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 7 EP applications Kine Birgit Thalsoe-Madsen has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 25, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12706234

A CYCLIC PEPTIDE AND CONJUGATE THEREOF FOR BINDING TO KERATINOCYTES

IPC classification:
A61K 47/48, C07K 7/64
Applicant:
Leo Pharma A/S
Agent:
Kine Birgit Thalsoe-Madsen, Leo Pharma A/S
Status:
GRANT OF PATENT INTENDED
EP12761808

DIAGNOSTIC MICRORNA PROFILING IN CUTANEOUS T-CELL LYMPHOMA (CTCL)

IPC classification:
C12Q 1/68
Applicant:
Leo Pharma A/S
Applicant:
University of Copenhagen (Københavns Universitet)
Applicant:
Rigshospitalet Københavns Universitet
Agent:
Høiberg A/S
Agent:
Kine Birgit Thalsoe-Madsen, Leo Pharma A/S
Status:
PATENT GRANTED
EP14190881

A pharmaceutical spray composition

IPC classification:
A61K 47/10, A61K 47/06, A61K 9/12, A61K 9/00
Agent:
Kine Birgit Thalsoe-Madsen, Leo Pharma A/S
Status:
EXAMINATION REQUESTED
EP13734410

A TOPICAL COMPOSITION COMPRISING A FILM-FORMING POLYMER FOR DELIVERING AN ACTIVE INGREDIENT TO SKIN

IPC classification:
A61K 9/70, A61K 9/00
Applicant:
Leo Pharma A/S
Agent:
Kine Birgit Thalsoe-Madsen, Leo Pharma A/S
Status:
GRANT OF PATENT INTENDED
EP13737817

A TOPICAL COMPOSITION COMPRISING A FILM-FORMING POLYMER FOR DELIVERING AN ACTIVE INGREDIENT TO SKIN

IPC classification:
A61K 9/70, A61K 9/12, A61K 9/00
Applicant:
Leo Pharma A/S
Agent:
Kine Birgit Thalsoe-Madsen, Leo Pharma A/S
Status:
GRANT OF PATENT INTENDED
EP14187329

Pharmaceutical composition for dermal use to treat psoriasis comprising a vitamin D and a corticosteroid

IPC classification:
A61K 47/10, A61K 47/06, A61K 31/593, A61K 31/59, A61K 31/573, A61K 31/56, A61K 9/00, A61P 17/06
Agent:
Kine Birgit Thalsoe-Madsen, Leo Pharma A/S
Status:
The patent has been granted
EP13798642

A METHOD OF INHIBITING THE EXPRESSION OF IL-22 IN ACTIVATED T-CELLS

IPC classification:
A61K 45/06, A61K 31/593, A61K 31/443, A61K 31/44, A61P 29/00, A61P 17/06
Applicant:
Leo Pharma A/S
Agent:
Kine Birgit Thalsoe-Madsen, Leo Pharma A/S
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature